DB (International) Stock Brokers Limited (NSE:DBSTOCKBRO)

Ligand Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	976.32	87.88	204.63	145.43	64.15
Trading Asset Securities	-	-	1.51	16.87	23.69	-
Accounts Receivable	-	8.77	12.9	17.9	16.41	14.25
Other Receivables	-	-	9.52	9.74	19.1	7.04
Property, Plant & Equipment	-	43.7	47.69	32.84	12.37	10.2
Other Intangible Assets	-	2.35	6.08	16.51	0.05	0.26
Investments in Debt & Equity Securities	-	6.16	-	-	232.79	8.25
Other Current Assets	-	57.2	1,119	744.42	493.67	458.65
Long-Term Deferred Tax Assets	-	1.82	1.35	-	0.25	7.86
Other Long-Term Assets	-	8.71	10.45	6.98	27.14	53.32
Total Assets	-	1,105	1,297	1,050	970.9	623.99
Accounts Payable	-	352.53	573.83	410.16	434.34	169.68
Accrued Expenses	-	-	3.36	1.18	6.37	7.2
Short-Term Debt	-	29.27	24.17	49.95	-	-
Current Portion of Leases	-	-	22.2	5.75	6.87	0.16
Other Current Liabilities	-	1.14	0.32	0.8	0.8	8
Long-Term Debt	-	-	9.95	9.87	15.16	14.7
Long-Term Leases	-	-	-	-	-	1.7
Long-Term Deferred Tax Liabilities	-	-	-	0.17	-	0.01
Other Long-Term Liabilities	-	1.87	0.03	-	-	0
Total Liabilities	-	384.8	633.86	477.87	463.53	204.54
Common Stock	-	70	70	70	70	70
Additional Paid-In Capital	-	-	76	76	76	76
Retained Earnings	-	-	511.77	421.07	358.98	271.63
Comprehensive Income & Other	-	650.23	5.21	4.94	2.39	1.82
Shareholders' Equity	720.23	720.23	662.98	572.02	507.37	419.45
Total Liabilities & Equity	-	1,105	1,297	1,050	970.9	623.99
Total Debt	29.27	29.27	56.32	65.56	22.03	16.56
Net Cash (Debt)	947.05	947.05	33.07	155.94	147.08	47.59
Net Cash Growth	-	2764.14%	-78.80%	6.02%	209.08%	-56.95%
Net Cash Per Share	27.06	27.00	0.94	4.46	4.20	1.36
Filing Date Shares Outstanding	34.78	35.34	35	35	35	35
Total Common Shares Outstanding	34.78	35.34	35	35	35	35
Working Capital	-	659.35	607.39	525.72	249.93	359.06
Book Value Per Share	20.38	20.38	18.94	16.34	14.50	11.98
Tangible Book Value	717.88	717.88	656.9	555.51	507.32	419.19
Tangible Book Value Per Share	20.31	20.31	18.77	15.87	14.49	11.98

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.